Velg din region

Velg regionen som passer best for din plassering eller dine preferanser.

International

Velg ditt nettstedsspråk

Denne innstillingen kontrollerer språket for brukergrensesnittet, inkludert knapper, menyer og all tekst på nettstedet. Velg ditt foretrukne språk for best brukeropplevelse.

Velg språk for stillingsannonser

Velg språkene for stillingsannonser du vil se. Denne innstillingen bestemmer hvilke stillingsannonser som vises for deg.

qSTAR Medical

Paris, Frankrike

Besøk nettside

Om arbeidsgiveren

qSTAR Medical aims to improve the lives of patients suffering from End Stage Renal Disease (ESRD) by developing an innovative vascular access device featuring STAR® Biomaterial.

qSTAR Medical SAS was established in late 2011 as a spinout of Healionics USA with the support of OSEO France to develop a needle-free percutaneous port system for improved, pain-free and cost-effective vascular access for hemodialysis (HD) therapy.

There are approximately 20 million patients worldwide who suffer from Chronic Kidney Disease (CKD). An estimated 10% of these patients (2m) have progressed to the severe loss of kidney function defined as End Stage Renal Disease (ESRD) which requires life-sustaining thrice-weekly or daily dialysis therapy. Vascular access is the "Achilles heel" of hemodialysis therapy due to its high complication rates. ESRD patients need and deserve better vascular access options – qSTAR was created to help.